Transition Therapeutics Completes $10,350,000 Bought Deal of ... (Hep C Chronic Fatigue)

Transition Therapeutics Completes $10,350,000 Bought Deal of ...
Canada NewsWire (press release), Canada - Jan 4, 2006... include regenerative therapies E1-INT(TM) and GLP1-INT(TM) for the treatment of diabetes, MS-IET for the treatment of multiple sclerosis and HCV-IET for the ...

Romark Laboratories to Develop Alinia as New Treatment for Chronic ...
EndoNurse, AZ - Jan 10, 2006... The patients were infected with HCV genotype 4. Approximately 10 percent of the patients had previously failed pegylated interferon and ribavirin combination ...

ViroPharma to Eliminate Debt
PR Newswire (press release), NY - Jan 26, 2006... ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). ...

Medivir: Candidate Drug Designated within the Tibotec ...
Genetic Engineering News, NY - Dec 29, 2005The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug (CD). The aim ...